Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0150WS28128970
   PubMed Web of Science ®Google Scholar
• Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med. 2010;182(5):598–604. doi:10.1164/rccm.200912-1843CC20522794
   PubMed Web of Science ®Google Scholar
• Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761–767. doi:10.1136/thx.2007.08919318728201
   PubMed Web of Science ®Google Scholar
• Mirza S, Benzo R. Chronic obstructive pulmonary disease phenotypes: implications for care. Mayo Clin Proc. 2017;92(7):1104–1112. doi:10.1016/j.mayocp.2017.03.02028688465
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American thoracic society. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77–121. doi:10.1164/ajrccm.152.1.75998367582322
   PubMed Web of Science ®Google Scholar
• Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100(10):1742–1752. doi:10.1016/j.rmed.2006.02.00316549342
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5Suppl 2):398s–401s. doi:10.1378/chest.117.5_suppl_2.398s10843984
   PubMed Web of Science ®Google Scholar
• Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD–a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009;4:203–223.19554195
   PubMedGoogle Scholar
• Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. Copd. 2010;7(3):214–228. doi:10.3109/15412555.2010.48169720486821
   PubMedGoogle Scholar
• Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• Le Rouzic O, Roche N, Cortot AB, et al. Defining the “frequent exacerbator” phenotype in COPD: a hypothesis-free approach. Chest. 2018;153(5):1106–1115. doi:10.1016/j.chest.2017.10.00929054347
   PubMed Web of Science ®Google Scholar
• McLachlan G. Cluster analysis and related techniques in medical research. Stat Methods Med Res. 1992;1(1):27–48. doi:10.1177/0962280292001001031341650
   PubMedGoogle Scholar
• Weatherall M, Shirtcliffe P, Travers J, Beasley R. Use of cluster analysis to define COPD phenotypes. Eur Respir J. 2010;36(3):472–474. doi:10.1183/09031936.0003521020930198
   PubMed Web of Science ®Google Scholar
• Lee JY, Chon GR, Rhee CK, et al. Characteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COpd subgroup study team cohort. J Korean Med Sci. 2016;31(4):553–560. doi:10.3346/jkms.2016.31.4.55327051239
   PubMed Web of Science ®Google Scholar
• Tsiligianni IG, van der Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12(1):20. doi:10.1186/1471-2466-12-2022607459
   PubMed Web of Science ®Google Scholar
• Burge PS, Calverley P, Jones PW, Spencer S, Anderson JA, Maslen T. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Bmj. 2000;320(7245):1297–1303. doi:10.1136/bmj.320.7245.129710807619
   PubMed Web of Science ®Google Scholar
• Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi:10.1164/ajrccm.166.1.at110212091180
   PubMed Web of Science ®Google Scholar
• Anon. Standardization of spirometry, 1994 update. American Thoracic society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC18480428
   PubMed Web of Science ®Google Scholar
• Vestbo J, Agusti A, Wouters EF, et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med. 2014;189(9):1022–1030. doi:10.1164/rccm.201311-2006PP24552242
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Diagnosis of asthma–COPD overlap: the five commandments. Eur Respiratory Soc. 2017. doi:10.1183/13993003.00506-2017
   Web of Science ®Google Scholar
• Caillaud D, Chanez P, Escamilla R, et al. Asthma-COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype? Allergy. 2017;72(1):137–145. doi:10.1111/all.1300427501862
   PubMed Web of Science ®Google Scholar
• Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int. 2018;67(2):172–178. doi:10.1016/j.alit.2018.01.00229433946
   PubMed Web of Science ®Google Scholar
• Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3):279–285. doi:10.3109/02770903.2011.55557621323613
   PubMed Web of Science ®Google Scholar
• Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127. doi:10.1186/1465-9921-12-12221951550
   PubMed Web of Science ®Google Scholar
• Menezes AMB, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-062224114498
   PubMed Web of Science ®Google Scholar
• Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341–350. doi:10.1183/09031936.0021601324876173
   PubMed Web of Science ®Google Scholar
• Duong-Quy S, Tran Van H, Vo Thi Kim A, Pham Huy Q, Craig TJ. Clinical and functional characteristics of subjects with asthma, COPD, and asthma-COPD overlap: a multicentre study in Vietnam. Can Respir J. 2018;2018. doi:10.1155/2018/1732946
   Web of Science ®Google Scholar
• Sakae TM, Pizzichini MMM, Teixeira PJZ, Silva R, Trevisol DJ, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. Jornal Brasileiro De Pneumologia. 2013;39(3):259–271. doi:10.1590/S1806-3713201300030000223857694
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Sato S, et al. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax. 2008;63(11):951–955. doi:10.1136/thx.2007.09285818535116
   PubMed Web of Science ®Google Scholar
• Lin YH, Tsai CL, Chien LN, Chiou HY, Jeng C. Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis–a nationwide population-based cohort study. Int J Clin Pract. 2015;69(3):350–357. doi:10.1111/ijcp.1250125359162
   PubMed Web of Science ®Google Scholar
• Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med. 2013;13(1):51. doi:10.1186/1471-2466-13-5123927016
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen TS, Marott JL, Vestbo J, Nordestgaard BG, Hallas J, Lange P. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology. 2015;20(1):101–107. doi:10.1111/resp.1242025297724
   PubMed Web of Science ®Google Scholar
• Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res. 2014;15(1):62. doi:10.1186/1465-9921-15-6224894541
   PubMed Web of Science ®Google Scholar
• Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J. 2004;23(6):841–845.15218995
   PubMed Web of Science ®Google Scholar
• Terada K, Muro S, Ohara T, et al. Abnormal swallowing reflex and COPD exacerbations. Chest. 2010;137(2):326–332. doi:10.1378/chest.09-048219783670
   PubMed Web of Science ®Google Scholar
• Sasaki T, Nakayama K, Yasuda H, et al. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc. 2009;57(8):1453–1457. doi:10.1111/j.1532-5415.2009.02349.x19515110
   PubMed Web of Science ®Google Scholar
• Asthma GIf. Global strategy for asthma management and prevention, 2018 Available from: www.ginasthma.org; 2018 Assessed 1 2018.
   Google Scholar
• Donaldson G, Seemungal T, Bhowmik A, Wedzicha J. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.84712324669
   PubMed Web of Science ®Google Scholar